Jun 4 |
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
|
May 23 |
Azenta to Participate in the Jefferies Global Healthcare Conference
|
May 13 |
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
|
May 10 |
Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges
|
May 9 |
The Analyst Landscape: 7 Takes On Azenta
|
May 8 |
Azenta, Inc. (AZTA) Q2 2024 Earnings Call Transcript
|
May 8 |
Azenta Non-GAAP EPS of $0.05 beats by $0.03, revenue of $159M misses by $0.86M
|
May 8 |
Azenta CEO Stephen Schwartz to retire
|
May 8 |
Azenta Announces CEO Succession Plan
|
May 8 |
Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
|